Are you working on these ATMP's or clearing a path to continuous biologics manufacturing? ISPE invites you to submit a proposal for our 2018 ISPE Biopharmaceutical Manufacturing Conference , December 10-12, Huntington Beach, CA
The 2018 ISPE Biopharmaceutical Manufacturing Conference focuses on the quickly evolving science of biologics manufacturing for new modalities, and the novel technologies that leverage existing capacity and move us towards continuous manufacturing. Share your expertise and help your peers prepare to manufacture these novel medicines and deliver on our promise of supplying life changing medicines to patients across the globe.
The call for proposals is open until May 30, 2018.
Clinical to Product Launch
Has your firm successfully navigated the journey from clinical to commercial? Share your story with a highly engaged Biopharms audience.
Regulatory/CMC/GMP/QA/Validation
How has your company’s quality processes evolved along with evolving Biopharmaceutical technologies, therapies and personal medicine?
Cost
Have you unlocked the challenge of efficient and sustainable manufacturing for new modalities? What Lean and Manufacturing Excellence processes have you implemented related to cost?
Facilities, Equipment, and Processes
Reduced scale, multiple concurrent batches, unique and stringent contamination challenges – do you have a success story of how your firm safely and reliably houses processes for new treatments?
Supply Chain
Future state of biomanufacturing requires new and higher levels of supply chain logistics and control. Personalized medicine presents unique chain of custody and logisitics challenges. Share your success in a compelling case study.
I speak for all the conference committee volunteers when I say we look forward to reading your proposals and learning how you are propelling the industry forward.
Andre Walker, BSChEng, CPIP, is a consultant with over 30 years of experience providing engineering and technical support for manufacturers of biopharmaceuticals, medical devices, and...
Following an unprecedented two years in which the pharmaceutical industry has faced numerous challenges posed by the global pandemic, pharmaceutical manufacturing has had to react and respond to meet the rapidly changing requirements and timelines. This has necessitated a radical rethink in how we...
Continuous manufacturing (CM) is gaining traction in pharmaceutical manufacturing. The purpose of this post is to highlight some of the differences between small molecule Drug Substance (DS) and Drug Product (DP) continuous manufacturing (CM), which may be helpful in considering the development and...
Gaelle Saint-Louis is the Women in Pharma® (WIP) Chair of the ISPE San Diego Chapter. She began her involvement with ISPE as the Young Professional (now Emerging Leaders) Chair for the Greater Los Angeles Chapter in 2019. After relocating to San Diego, she took on a leadership role within the...
